Table 1 Clinical and phenotypic data in... | American Society of Hematology

Table 1

Clinical and phenotypic data in 47 cases of pDC neoplasms

Case no.	Age, y/sex	Site of involvement	CD4	CD45RA	CD43	CD56	CD123	TCL1	TdT
CD4⁺CD56⁺ hematodermic neoplasm
1	77/F	Skin	+	+	+	+	Scat'rd+	nd	Scat'rd+
2	73/F	Skin	+	nd	nd	−	nd	nd	+
3	61/M	Skin and bone marrow	+	+	+	+ (30%)	+	+	−
4	67/M	Skin	+	nd	+	+	+	+	−
5	60/M	Skin	+	+	+	+	+	+	+
6	80/M	Bone marrow	+	+	+	+	+	+	–
7	51/M	Bone marrow	+	+	+	+	+	nd	–
8	75/M	Skin	+	+	+	+	–	+	–
9	78/F	Spleen	+	+	+	+	+	+	–
10	80/M	Skin	+	+	+	–	+	+	–
11	78/M	Bone marrow	+	+	+	+	+	+	–
12	45/F	na	+	+	+	+	+	+	–
13	58/M	Bone marrow	+	+	+	+	+	+	–
14	71/M	Skin	+	+	+	+	+	+	+
15	72/M	Skin	+	+	+	+	+	nd	–
16	30/M	Skin	+	+	+	+/−	+	+	−/+
17	na	na	+	+	+	+/−	+	+	+/−
18	31/M	Skin	+	+	+	+	+	+	−/+
19	57 M	Skin, lymph node, and bone marrow	+	nd	+	+	nd	nd	+
20	68 F	Skin	+	nd	+	+	nd	nd	+
21	12 F	Skin	+	nd	+	+	nd	nd	+
22	25/F	Skin	+	nd	+	+	+	+	nd
23	77/M	Skin	+	+	+	+	+	+	−
24	35/F	Skin	+	nd	+	+	+	+	−
25	80/M	Skin	+	nd	nd	+	nd	nd	nd
26	96/F	Skin	+	nd	+	+	+	+	+ (30%)
27	73/M	Skin	+	nd	+	+	+	+	−
28	76/M	Skin	+	nd	+	+	+	+	+ (50%)
29	54/F	Skin	+	nd	−	+	+	+	+ (80%)
30	71/M	Skin	+	nd	+	+	+	+	−
31	63/M	Skin	+	nd	nd	+	+	+	+ (10%)
32	8/M	Skin	+	+	+	+	+	+	−
33	64/M	Lymph node	+	nd	+	+	nd	+	+
34	84/M	Skin	+	+	+	+	+	+	−
35	60/F	Skin	+	nd	nd	+	nd	nd	nd
36	83/M	Skin	+	nd	nd	+	+	+	−
37	75/M	Skin	+	nd	+	+	+	+	−
38	25/M	Skin	+	nd	nd	+	+	+	−
39	70/F	Skin	+	nd	+	+	nd	+	−
40	88/F	Skin	+	+	+	+	+	+	+ (10%)
41	72/M	Skin	+	+	+	+	+	+	−
pDC proliferations associated with a myeloproliferative disorder
42	52/M	Lymph node	+	+	+	(+)	+	+	−
43	63/F	Lymph node	+	+	+	(+)	+	(+)	−
44	24/M	Lymph node and skin	+	+	+	−	+	(+)	−
45	62/F	Lymph node	+	+	+	−	+	(+)	−
46	65/M	Lymph node	+	nd	+	(+)	+	+	−
47	71/M	Bone marrow	+	+	+	−	+	nd	−

Case no.	Age, y/sex	Site of involvement	CD4	CD45RA	CD43	CD56	CD123	TCL1	TdT
CD4⁺CD56⁺ hematodermic neoplasm
1	77/F	Skin	+	+	+	+	Scat'rd+	nd	Scat'rd+
2	73/F	Skin	+	nd	nd	−	nd	nd	+
3	61/M	Skin and bone marrow	+	+	+	+ (30%)	+	+	−
4	67/M	Skin	+	nd	+	+	+	+	−
5	60/M	Skin	+	+	+	+	+	+	+
6	80/M	Bone marrow	+	+	+	+	+	+	–
7	51/M	Bone marrow	+	+	+	+	+	nd	–
8	75/M	Skin	+	+	+	+	–	+	–
9	78/F	Spleen	+	+	+	+	+	+	–
10	80/M	Skin	+	+	+	–	+	+	–
11	78/M	Bone marrow	+	+	+	+	+	+	–
12	45/F	na	+	+	+	+	+	+	–
13	58/M	Bone marrow	+	+	+	+	+	+	–
14	71/M	Skin	+	+	+	+	+	+	+
15	72/M	Skin	+	+	+	+	+	nd	–
16	30/M	Skin	+	+	+	+/−	+	+	−/+
17	na	na	+	+	+	+/−	+	+	+/−
18	31/M	Skin	+	+	+	+	+	+	−/+
19	57 M	Skin, lymph node, and bone marrow	+	nd	+	+	nd	nd	+
20	68 F	Skin	+	nd	+	+	nd	nd	+
21	12 F	Skin	+	nd	+	+	nd	nd	+
22	25/F	Skin	+	nd	+	+	+	+	nd
23	77/M	Skin	+	+	+	+	+	+	−
24	35/F	Skin	+	nd	+	+	+	+	−
25	80/M	Skin	+	nd	nd	+	nd	nd	nd
26	96/F	Skin	+	nd	+	+	+	+	+ (30%)
27	73/M	Skin	+	nd	+	+	+	+	−
28	76/M	Skin	+	nd	+	+	+	+	+ (50%)
29	54/F	Skin	+	nd	−	+	+	+	+ (80%)
30	71/M	Skin	+	nd	+	+	+	+	−
31	63/M	Skin	+	nd	nd	+	+	+	+ (10%)
32	8/M	Skin	+	+	+	+	+	+	−
33	64/M	Lymph node	+	nd	+	+	nd	+	+
34	84/M	Skin	+	+	+	+	+	+	−
35	60/F	Skin	+	nd	nd	+	nd	nd	nd
36	83/M	Skin	+	nd	nd	+	+	+	−
37	75/M	Skin	+	nd	+	+	+	+	−
38	25/M	Skin	+	nd	nd	+	+	+	−
39	70/F	Skin	+	nd	+	+	nd	+	−
40	88/F	Skin	+	+	+	+	+	+	+ (10%)
41	72/M	Skin	+	+	+	+	+	+	−
pDC proliferations associated with a myeloproliferative disorder
42	52/M	Lymph node	+	+	+	(+)	+	+	−
43	63/F	Lymph node	+	+	+	(+)	+	(+)	−
44	24/M	Lymph node and skin	+	+	+	−	+	(+)	−
45	62/F	Lymph node	+	+	+	−	+	(+)	−
46	65/M	Lymph node	+	nd	+	(+)	+	+	−
47	71/M	Bone marrow	+	+	+	−	+	nd	−

+ indicates all tumor cells are positive; (+), almost all tumor cells are weakly positive; +/−, most of the tumor cells are positive; Scat'rd+, scattered tumor cells are positive; −/+, most of the tumor cells are negative; –, all tumor cells are negative; nd, not done; and na, data not available.

View Large

This Feature Is Available To Subscribers Only